Results 21 to 30 of about 19,655 (167)

Combined oral propranolol with intralesional injection of triamcinolone acetonide in treatment of infantile periocular hemangiomas [PDF]

open access: yes, 2017
Alahmady H Alsmman, Amr Mounir Department of Ophthalmology, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt Aim: To evaluate the clinical effectiveness of combined oral propranolol with intralesional injection of triamcinolone acetonide in ...
Amr Mounir   +3 more
core   +1 more source

Combinative effects of β-elemene and propranolol on the proliferation, migration, and angiogenesis of hemangioma [PDF]

open access: yesPeerJ, 2023
Hemangioma (HA) is one of the most common benign vascular tumors among children. Propranolol is used as the first-line treatment for hemangioma and is a non-selective blocker of the β-adrenergic receptor.
Zhenyu Wang   +4 more
doaj   +2 more sources

Photostability of Propranolol [PDF]

open access: yes, 2004
An 'one dose package system' has become popular for convenience of the patient. But the quality of drugs and the measurement of their photostabilities are renounced by this system. Propranolol, a β-adrenoreceptor blocking agent, is widely used for angina
千葉, 貴志   +14 more
core   +1 more source

Efficacy and safety assessment of propranolol tablets vs. oral solution for infantile hemangioma: a retrospective study in China

open access: yesFrontiers in Pediatrics
BackgroundPropranolol for infantile hemangiomas (IHs) is effective and relatively safe. However, propranolol has different formulations and there is no consensus on the optimal formulation for IHs.
Wenting Chen   +8 more
doaj   +1 more source

Low-Dose Propranolol Prevents Functional Decline in Catecholamine-Induced Acute Heart Failure in Rats

open access: yesToxics, 2022
Severe hyper-catecholaminergic states likely cause heart failure and cardiac fibrosis. While previous studies demonstrated the effects of beta-blockade in experimental models of single-catecholamine excess states, the detailed benefits of beta-blockade ...
Cheng-Ken Tsai   +6 more
doaj   +1 more source

Propranolol in Treatment of Huge and Complicated Infantile Hemangiomas in Egyptian Children

open access: yesDermatology Research and Practice, 2014
Background. Infantile hemangiomas (IHs) are the most common benign tumours of infancy. Propranolol has recently been reported to be a highly effective treatment for IHs.
Basheir A. Hassan, Khalid S. Shreef
doaj   +1 more source

Deep coma in a child treated with propranolol for infantile hemangioma

open access: yesBMC Pediatrics, 2019
Background Propranolol hydrochloride is the first-line agent recommended for the treatment of infantile hemangiomas (IH). Serious adverse effects of propranolol therapy for hemangiomas are infrequent.
Ilirjana Bakalli   +7 more
doaj   +1 more source

Trigeminovascular effects of propranolol in men and women, role for sex steroids

open access: yesAnnals of Clinical and Translational Neurology, 2022
Objective Assess whether propranolol modulates the trigeminovascular system in both men and women. Methods We investigated the effect of propranolol (80 mg, 90 min after oral administration, corresponding to Tmax) on the increase in dermal blood flow of ...
Eloísa Rubio‐Beltrán   +10 more
doaj   +1 more source

A Novel IDO1/NE Dual Inhibitor, IMM‐H018 Prevents the Primary and Secondary Sepsis and Ameliorates the Kidney Injury Through Inhibiting the Cytokine Storm and Microthrombosis, and Reversing Immunosuppression

open access: yesAdvanced Science, EarlyView.
IMM‐H018, a dual IDO1/NE inhibitor, demonstrates potent therapeutic efficacy in sepsis by simultaneously targeting excessive inflammation and immune dysfunction. It prevents both primary and secondary sepsis through anti‐inflammatory, immune‐restoring, and renoprotective mechanisms, reducing organ damage, improving immune homeostasis, preserving kidney
Yi Zhou   +11 more
wiley   +1 more source

Molecular Glue Degraders Enhance CAPRIN1‐Dependent Lysosomal Degradation of APP and Reduce Amyloid β in Alzheimer's Disease

open access: yesAdvanced Science, EarlyView.
A new class of lysosome‐directed molecular glue degraders selectively enhance CAPRIN1–APP interactions, driving APP degradation and reducing amyloid‐β production in human neurons and Alzheimer's disease mouse models. This CAPRIN1‐dependent targeted protein degradation strategy reveals a previously unrecognized therapeutic approach for disrupting the ...
Sunghan Jung   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy